Member Info for easyp

"Within the next few weeks the UK government has to make an important decision that is fundamental to its energy policy and, indeed, to its view of the role of state in economic life. The immediate question is whether public money should be used to rescue the proposed power plant at Wylfa in Anglesey, Wales. As reported in the FT last year, Duncan Hawthorne � head of the Hitachi consortium that aims to build the plant � does not believe the project can proceed without an agreement with the government on the financing structure. He says Hitachi cannot be expected to keep �burning money�. The implication is that public sector capital has to be involved. Nuclear power requires big upfront investment. It is hard to imagine anything below �5bn would make a material difference." Todays FT.

So far so bad!

"The Trump administration is overturning a longstanding tenet of US energy policy by proposing to open a huge swath of federal waters to oil and gas drilling, a move likely to spark a drawn-out battle between oil companies, environmentalists and politicians. The US interior department on Thursday unveiled plans to make about 90 per cent of federal waters available for drilling, in response to a 2017 executive order from President Donald Trump."

Yes but quietly does it. I want to see the market makers squirm as we few, we patient few hold our shares and twist their arms for a good price. First psychological price barrier probably around 80p then upwards of 100p.

https://www.statista.com/statistics/266134/novartis-expenditure-on-research-and-development-since-2004/ If the link works correctly you should be able to see that Novartis spent $8 Billion on R & D in 2016. Now if you were the CEO and could buy a controlling stake in OXB for $150 million might you not be tempted to offer a cash and shares bid?

Dude, that is rather like demanding to know why a shark just bit a nice little seal in two and then swallowed the debris? Its what they do and therefore part of the background noise on boards like this. Suggest you stick with PMG a little while longer as you may recover some of your losses.

Buzz, I will be happy if PMG stays above 40p today. They say a week is a long time in politics but its an age when hoping for better from PMG.

SP up due to media attention and general optimism about the biotech sector imo. Lurking in the background the chance of a bid. Follow the momentum for the time being.

Fasten your seat belts, turbulence time!

Nooooooooooo! Just for a minute, a happy minute I thought bid time!

In anticipation of that just purchased some more!

Hi, any idea what the net asset value is of a share in PMG? FT tearsheet out of date by 2 years but suggested 70p. I remain suspicious of the management and market makers but feel this is way undervalue at 36p.

Nice start to the day up 2.1%. Where will sp rise come from? Institutional buyers and small investors? If you were running a biotech fund OXB might well attract your attention.

"The time is right for investors to buy shares of oilfield services and equipment companies, says Credit Suisse analyst James Wicklund. �The oilfield services sector - after suffering the sharpest decline in history followed by the sharpest recovery - is back to what appears to be at least a three-plus year run of somewhat normal growth,� Wicklund writes, expecting oil E&P spending to increase by ~12% in 2018. Wicklund points to the industry�s �dramatic efforts to reduce costs and improve operating efficiencies,� as helping to set up a multiyear recovery."

Hoping to see a bid this year. Would the management bother with fund raising when Novartis could take a stake?

I could say the same of easyjet.

It seems the wicked market makers were asleep this morning and allowed the sp to rise. Just before lunch one of them spotted that and shorted it back down again.

You are not wrong on the 52 week low but you did seem confident that the Flybe sp would drop to 27p in comments made last year. I hope you are wrong as I am a shareholder and down about 12%!

If nothing else the mention will attract a few hundred small buys when the market opens. I might buy a few more myself as the support from The Times is encouraging.

http://www.bbc.co.uk/news/resources/idt-sh/disruptors_what_will_the_doctor_order Worth a read as it mentions T Cells and Novartis. As below I also think a TO likely within months not years. The price will depend on what value is put on the science delivered thus far but the UK Biotech scene must look cheap to big US Pharma.